Wolverine Trading’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.27M | Buy |
+8,596
| New | +$1.3M | ﹤0.01% | 2644 |
|
|
2025
Q2 | – | Sell |
-37,087
| Closed | -$5.47M | – | 4734 |
|
|
2025
Q1 | $5.47M | Buy |
37,087
+31,096
| +519% | +$4.5M | 0.01% | 942 |
|
|
2024
Q4 | $786K | Buy |
5,991
+3,138
| +110% | +$439K | ﹤0.01% | 2912 |
|
|
2024
Q3 | $443K | Buy |
2,853
+1,304
| +84% | +$210K | ﹤0.01% | 3181 |
|
|
2024
Q2 | $242K | Sell |
1,549
-9,793
| -86% | -$1.47M | ﹤0.01% | 3639 |
|
|
2024
Q1 | $1.54M | Buy |
11,342
+6,169
| +119% | +$817K | ﹤0.01% | 1818 |
|
|
2023
Q4 | $697K | Sell |
5,173
-21,115
| -80% | -$2.74M | ﹤0.01% | 2622 |
|
|
2023
Q3 | $3.56M | Buy |
+26,288
| New | +$3.59M | ﹤0.01% | 1203 |
|
|
2023
Q2 | – | Sell |
-19,715
| Closed | -$2.9M | – | 4235 |
|
|
2023
Q1 | $2.73M | Buy |
19,715
+5,183
| +36% | +$697K | ﹤0.01% | 1174 |
|
|
2022
Q4 | $1.97M | Buy |
14,532
+6,832
| +89% | +$857K | ﹤0.01% | 1394 |
|
|
2022
Q3 | $846K | Buy |
7,700
+5,175
| +205% | +$657K | ﹤0.01% | 2117 |
|
|
2022
Q2 | $338K | Sell |
2,525
-4,292
| -63% | -$563K | ﹤0.01% | 2937 |
|
|
2022
Q1 | $915K | Buy |
+6,817
| New | +$818K | ﹤0.01% | 2525 |
|
|
2021
Q4 | – | Sell |
-14,477
| Closed | -$1.73M | – | 5799 |
|
|
2021
Q3 | $1.73M | Buy |
+14,477
| New | +$1.69M | ﹤0.01% | 2321 |
|
|
2021
Q2 | – | Sell |
-11,752
| Closed | -$1.17M | – | 5939 |
|
|
2021
Q1 | $1.17M | Sell |
11,752
-13,362
| -53% | -$1.34M | ﹤0.01% | 2541 |
|
|
2020
Q4 | $2.52M | Sell |
25,114
-3,204
| -11% | -$339K | ﹤0.01% | 1517 |
|
|
2020
Q3 | $3.12M | Buy |
28,318
+11,357
| +67% | +$1.26M | 0.01% | 1150 |
|
|
2020
Q2 | $1.79M | Sell |
16,961
-3,855
| -19% | -$398K | ﹤0.01% | 1500 |
|
|
2020
Q1 | $1.85M | Buy |
20,816
+10,545
| +103% | +$993K | 0.01% | 1412 |
|
|
2019
Q4 | $1.03M | Buy |
+10,271
| New | +$967K | ﹤0.01% | 2385 |
|
|
2019
Q1 | – | Sell |
-4,755
| Closed | -$359K | – | 4502 |
|
|
2018
Q4 | $359K | Buy |
4,755
+2,031
| +75% | +$159K | ﹤0.01% | 2996 |
|
|
2018
Q3 | $216K | Sell |
2,724
-7,716
| -74% | -$584K | ﹤0.01% | 4167 |
|
|
2018
Q2 | $730K | Hold |
10,440
| – | – | ﹤0.01% | 2593 |
|
|
2018
Q1 | $730K | Buy |
+10,440
| New | +$723K | ﹤0.01% | 2593 |
|
|
2017
Q2 | – | Sell |
-9,713
| Closed | -$634K | – | 4256 |
|
|
2017
Q1 | $606K | Buy |
9,713
+1,661
| +21% | +$96.7K | ﹤0.01% | 2178 |
|
|
2016
Q4 | $440K | Buy |
+8,052
| New | +$457K | ﹤0.01% | 2777 |
|
Other funds holding AZN
Wolverine Trading's AZN Position: Q3 2025 in Review
Wolverine Trading opened a new position in AstraZeneca (AZN) in Q3 2025: 8,596 shares worth $1.27M. The stake represents ﹤0.01% of the portfolio and ranks #2644 among its holdings. This is a return to the name: Wolverine Trading previously reported a position in AZN as recently as Q1 2025.
Wolverine Trading first reported a position in AZN in Q4 2016 and has held it in 26 quarters since. The position peaked at $5.47M in Q1 2025. 1,288 funds tracked by Wall St. Rank hold AZN as of Q3 2025.
- Wolverine Trading held 8,596 shares of AstraZeneca worth $1.27M as of Q3 2025.
- AstraZeneca was a new Wolverine Trading position in Q3 2025.
- AstraZeneca made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #2644 holding.
- Wolverine Trading first reported a position in AstraZeneca in Q4 2016 and has held it in 26 quarters since.
- Wolverine Trading's AstraZeneca position peaked at $5.47M in Q1 2025.
- 1,288 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2025.
Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.